The efficacy of a long-pulsed 755-nm alexandrite laser for treatment of enlarged facial pores, a prospective clinical trial
Phase 3
- Conditions
- Healthy patient who has visibly enlarged pores on both side of the cheeks and the noseenlarged pores, dilated pores, facial pores, long-pulsed alexandrite laser
- Registration Number
- TCTR20230822001
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Healthy male or female subjects between ages 25-60 years old
-Subject who has visibly enlarged pores (0.1-0.6 mm2) on both side of the cheeks and the nose.
Exclusion Criteria
-Pregnancy, immediate postpartum or lactation
-Patients who demonstrated any underlying eczema and/or photodermatosis on the face
-Patients who demonstrated any skin infection or wound on the face
-Patients who were currently using photosensitizing medication
-Patients with a history of laser and/or energy-based device (EBD) treatment on their face within preceding 6 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method number of pore counted baseline, 2 wk, 4 wk, 8 wk pore analysis algorithm by VISIA
- Secondary Outcome Measures
Name Time Method Pore volume baseline, 2 wk, 4 wk, 8 wk Anthera 3D,Mean pore diameter baseline, 2 wk, 4 wk, 8 wk Fotofinder,Patient's satisfaction score at 8 wk Patient Satisfaction Scale(0-10),Clinical improvement rate 2 wk, 4 wk, 8 wk Global Aesthetic Improvement scale (GAIS) (excellent improvement, marked improvement, moderate improvement, minimal improvement)